Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma-Reference-Cited by-同舟云学术

Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma

Published:2023-11 Issue:6 Volume:8 Page:101279
ISSN:2452-1094
Container-title:Advances in Radiation Oncology
language:en
Short-container-title:Advances in Radiation Oncology

Author:

Wu Susan Y.^ORCID,Fang Penny Q.,Wang Ethan B.,Ahmed Sairah,Duvic Madeleine,Jain Preetesh,Castillo Luis E. Malpica,Nair Ranjit,Steiner Raphael E.,Strati Paolo,Huen Auris O.,Iyer Swaminathan P.,Pinnix Chelsea C.,Dabaja Bouthaina S.,Gunther Jillian R.^ORCID

Funder

National Cancer Institute

Bristol-Myers Squibb

National Institutes of Health

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference30 articles.

1. cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity;Francisco;Blood,2003

2. Results of a phase II trial of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma and lymphomatoid papulosis;Duvic;J Clin Oncol,2015

3. Nivolumab combined with brentuximab vedotin for relapsed/refractory primary mediastinal large B-cell lymphoma: Efficacy and safety from the phase II checkmate 436 study;Zinzani;J Clin Oncol,2019

4. Efficacy of brentuximab vedotin in relapsed or refractory high-CD30-expressing non-Hodgkin lymphomas: Results of a multicenter, open-labeled phase II trial;Kim;Cancer Res Treat,2020

5. Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression;Jacobsen;Blood,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stable use of radiotherapy in lymphoma patients over time – A comprehensive national overview of radiotherapy use in Sweden with focus on older patients;Clinical and Translational Radiation Oncology;2024-05

2. Ulcerating skin lesions from blastic plasmacytoid dendritic cell neoplasm responding to low-dose radiotherapy—a case report and literature review;Strahlentherapie und Onkologie;2024-01-29